Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Ivana_Magovčević-Liebisch
|
| gptkbp:developedBy |
therapies for rare and common neurodegenerative diseases
|
| gptkbp:focusesOn |
neurodegenerative diseases
microglia biology |
| gptkbp:foundedYear |
2020
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vigil Neuroscience
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:VIGL
|
| gptkbp:website |
https://www.vigilneuro.com/
|
| gptkbp:bfsParent |
gptkb:Mark_Leschly
|
| gptkbp:bfsLayer |
6
|